Sellgren, Carl M. https://orcid.org/0000-0001-9103-2785
Gracias, Jessica
Watmuff, Bradley
Biag, Jonathan D. https://orcid.org/0000-0003-0891-9567
Thanos, Jessica M. https://orcid.org/0000-0001-7984-5361
Whittredge, Paul B.
Fu, Ting
Worringer, Kathleen
Brown, Hannah E.
Wang, Jennifer
Kaykas, Ajamete
Karmacharya, Rakesh
Goold, Carleton P.
Sheridan, Steven D.
Perlis, Roy H. https://orcid.org/0000-0002-5862-6757
Article History
Received: 16 October 2017
Accepted: 19 December 2018
First Online: 4 February 2019
Competing interests
: C.P.G., A.K., K.W., P.B.W., and J.D.B. are employees of Novartis. R.H.P. has served on the scientific advisory boards of Genomind and Psy Therapeutics, and was a consultant to RID Ventures and Takeda (none related to the present work). C.M.S. discloses lecture and consulting fees from Otsuka Pharmaceutical and H. Lundbeck A/S (none related to the present work). None of the other authors declare any competing interests.